CNR1 and cancer: Bogdanović et al. [7] investigated the proapoptotic and antiproliferative effects of cannabinoids and associated signaling pathways in different cancer cell lines, and it has been demonstrated that natural and synthetic cannabinoids cause a CB1 and/or CB2 receptor-dependent decrease in the proliferation of breast and intestinal cancer cells [5,8].